MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0139043
Nectar Drugs Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹50.75 Cr
▼ 17% YoY
Net profit · FY 2025
₹33.13 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹58.78 Lakh
EBITDA margin 1.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹1.25 Cr
No open charges
Company age
29 yrs
Est. 1997
Directors on board
2
As per MCA filings
About Nectar Drugs Private Limited
Data last updated:
Nectar Drugs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 November 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1997PTC111699. Its GSTIN is 27AAACN3558R1ZT (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deven Hematlal Badani and Rajesh Hematlal Badani.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/605/606 Bhaveshwar Arcadelbs Marg Ghatkopar(W), Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.75 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹33.13 Lakh (net margin 0.7%) and EBITDA of ₹58.78 Lakh (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 2% over five years.
As per MCA filings, the company has satisfied charges of ₹1.25 Cr on record. Court records list 27 cases involving the company, including 18 filed by the company and 9 filed against it; 4 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2024. Its 6 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 4 smaller; the largest is Nutron Pharmaceuticals Private Limited with revenue of ₹51.48 Cr.
Nectar Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0139043). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nectardrugs.com.
Company details
CIN U24230MH1997PTC111699
Registration Number 111699
Incorporation Date 05 November 1997
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0139043
Recognitions & Rankings of Nectar Drugs
Contact details
Nectar Drugs Private Limited's registered office is in Mumbai, Maharashtra. Its website is nectardrugs.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressB/605/606 Bhaveshwar Arcadelbs Marg Ghatkopar(W), Mumbai, Maharashtra, India – 400086
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nectar Drugs Private Limited, buy the company report.
Comprehensive company report
Nectar Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nectar Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nectar Drugs Private Limited, buy the company report.
Financials of Nectar Drugs Private Limited
FY 2025 filings availableNectar Drugs Private Limited reported revenue of ₹50.75 Cr (down 17% YoY) for FY 2025.
Revenue · FY 2025
₹50.75 Cr ▼ 17%
Net profit · FY 2025
₹33.13 Lakh margin 0.7%
EBITDA · FY 2025
₹58.78 Lakh margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 14%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 51%
3 years · compounded
▲ 3%
5 years · compounded
▼ 1%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 17% fall in the latest year. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nectar Drugs Private Limited, buy the company report.
Board of directors of Nectar Drugs Private Limited
Nectar Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deven Hematlal Badani | Director | 05 Nov 1997 | 28 Years 11 Months | Current |
| Rajesh Hematlal Badani | Director | 05 Nov 1997 | 28 Years 11 Months | Current |
Peer comparison
Nectar Drugs Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nutron Pharmaceuticals Private Limited | ₹51.48 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Avsplus Pharma Private Limited | ₹50.81 Cr (FY 2023) | 28.0% | Mumbai, Maharashtra, India | |||
| Nectar Drugs Private Limitedthis company | ₹50.75 Cr (FY 2025) | ₹33.13 Lakh | 0.7% | -17.0% | Mumbai, Maharashtra, India | |
| SG Pharma Distributors Private Limited | ₹50.62 Cr (FY 2024) | 22.0% | Delhi, India | |||
| Banmala Commercial Pvt.Ltd. | ₹50.58 Cr (FY 2024) | 10.0% | 24Pgs North, West Bengal, India | |||
| Uni Agencies Chemicals Private Ltd | ₹50.45 Cr (FY 2024) | -4.0% | New Delhi, Delhi, India | |||
| General Drug Private Limited | ₹50.21 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Nectar Drugs Private Limited, buy the company report.
Auditor
Nectar Drugs Private Limited is audited by J R SUMONDY & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J R SUMONDY & CO | FY 2021 | 110553W |
Shareholding
The shareholding of Nectar Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nectar Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹1.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2001 | 90143318 | The Lakshmi Vilas Bank Limited | ₹1.25 Cr | Satisfied |
To see the full charge records of Nectar Drugs Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Nectar Drugs Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2024.
Total deals
2
Secondary share transfers
2
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Apr 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nectar Drugs Private Limited has 27 court cases on record: 18 filed by Nectar Drugs, 9 filed against it. 4 cases are pending and 23 are disposed.
Total cases
27
Filed by the company
18
Filed against the company
9
Pending
4
Disposed
23
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 27 | 9 | 4 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed by the company against Somil Enterprises Pvt. Ltd. and 2 others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed against the company by an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed against the company by an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against M/S. Chemitex India and 1 other | Pending |
To see the full case history of Nectar Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nectar Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nectar Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACN3558R1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nectar Drugs Private Limited, buy the company report.
Recent activity
Nectar Drugs Private Limited has 3 board changes on record since 1997: 2 appointments and 1 cessation. The latest: Hematlal Bhimji Badani ceased to be Director on 04 Oct 2011.
AGM
Nectar Drugs Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Nectar Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 21 Mar 2001 via Charge ID 90143318 with The Lakshmi Vilas Bank Limited was fully satisfied on 15 Nov 2019.
Ceased
Hematlal Bhimji Badani ceased to be Director.
Charges
A charge with The Lakshmi Vilas Bank Limited of Rs. 125.00 Lakh registered on 21 Mar 2001 with Charge ID 90143318 was modified on 30 Nov 2010.
Charges
A charge with The Lakshmi Vilas Bank Limited amounted to Rs. 125.00 Lakh with Charge ID 90143318 was registered on 21 Mar 2001.
Appointed
Deven Hematlal Badani was appointed as Director.
Appointed
Rajesh Hematlal Badani was appointed as Director.
Incorporation
05 Nov 1997
Nectar Drugs Private Limited was registered on 05 Nov 1997 with Roc Mumbai & aged 28 years 11 months as per MCA records.
Frequently asked questions
Nectar Drugs is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 November 1997 (29+ years old) and is registered under CIN U24230MH1997PTC111699.
Nectar Drugs has 2 current directors:
- Deven Hematlal Badani - Director
- Rajesh Hematlal Badani - Director
The latest financial statements of Nectar Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nectar Drugs is 27AAACN3558R1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nectar Drugs is U24230MH1997PTC111699. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nectar Drugs has 27 court cases on record: 18 filed by the company and 9 filed against it. 4 are pending.
Nectar Drugs was incorporated on 05 November 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
Nectar Drugs has 2 deals on record (2 secondary share transfers); the latest was in March 2024.
The peers of Nectar Drugs by revenue are Nutron Pharmaceuticals Private Limited, Avsplus Pharma Private Limited, SG Pharma Distributors Private Limited, Banmala Commercial Pvt.Ltd, Uni Agencies Chemicals Private Ltd and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Hematlal Bhimji Badani ceased to be Director on 04 Oct 2011. Deven Hematlal Badani was appointed as Director on 05 Nov 1997. Rajesh Hematlal Badani was appointed as Director on 05 Nov 1997.
Yes, Nectar Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0139043).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages